我将如何管理一位有症状且有高加重风险的慢性阻塞性肺疾病患者：来自挪威的基层医疗视角
How I would manage a man with COPD who is symptomatic and at high risk of an exacerbation: a primary care perspective from Norway.
作者信息
Henrichsen Svein Høegh
机构信息
GP, Langbolgen legesenter, 1150-Oslo, Norway.
出版信息
Prim Care Respir J. 2012 Dec;21(4):448-9. doi: 10.4104/pcrj.2012.00100.
Abstract
Clinical scenario A 69 year-old man attends for a follow-up appointment two weeks after being hospitalised for an exacerbation of COPD. He is improving, though not yet back to normal. He quit smoking after a previous recent admission with a severe exacerbation. Spirometry last year recorded an FEV/FVC ratio of 0.36 and a post-bronchodilator FEV of 29% predicted. He is currently taking a combination long-acting β-agonist/inhaled corticosteroid inhaler and a long-acting antimuscarinic.
摘要
临床病例A：一名69岁男性因慢性阻塞性肺疾病（COPD）急性加重住院两周后前来复诊。他正在好转，但尚未恢复正常。他在最近一次因严重急性加重入院后戒烟。去年的肺功能检查显示FEV/FVC比值为0.36，支气管扩张剂后FEV为预测值的29%。他目前正在使用长效β受体激动剂/吸入性糖皮质激素联合吸入器和长效抗胆碱能药物。
相似文献
1
How I would manage a man with COPD who is symptomatic and at high risk of an exacerbation: a primary care perspective from Norway.我将如何管理一位有症状且有高加重风险的慢性阻塞性肺疾病患者：来自挪威的基层医疗视角
Prim Care Respir J. 2012 Dec;21(4):448-9. doi: 10.4104/pcrj.2012.00100.
2
[Chronic obstructive pulmonary disease (COPD): diagnosis and treatment].[慢性阻塞性肺疾病（COPD）：诊断与治疗]
Dtsch Med Wochenschr. 2004 Mar 5;129(10):490-3. doi: 10.1055/s-2004-820537.
3
Treatment patterns for patients hospitalized with chronic obstructive pulmonary disease.慢性阻塞性肺疾病住院患者的治疗模式
Am J Health Syst Pharm. 2018 Mar 15;75(6):359-366. doi: 10.2146/ajhp160979.
4
Drugs in clinical development for chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病的临床开发中的药物。
Respiration. 2005 Jan-Feb;72(1):105-12. doi: 10.1159/000083411.
5
Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.长效支气管扩张剂治疗慢性阻塞性肺疾病
Ann Pharmacother. 2008 Dec;42(12):1832-42. doi: 10.1345/aph.1L250. Epub 2008 Oct 28.
6
[Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
MMW Fortschr Med. 2003 Nov 13;145(46):47.
7
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.慢性阻塞性肺疾病的药物治疗：一项混合治疗比较的荟萃分析。
Pharmacotherapy. 2009 Aug;29(8):891-905. doi: 10.1592/phco.29.8.891.
8
A step forward in COPD management: reading between the lines.慢性阻塞性肺疾病管理的新进展：透过字里行间解读
Chest. 2012 Nov;142(5):1082-1085. doi: 10.1378/chest.12-0981.
9
To add, or not to add an inhaled corticosteroid in moderate COPD: that is the question.在中度慢性阻塞性肺疾病（COPD）中，是否添加吸入性糖皮质激素：这就是问题所在。
Chest. 2008 Aug;134(2):223-225. doi: 10.1378/chest.08-0855.
10
Comparison table: Inhaled short-acting bronchodilators for treatment of COPD.比较表：用于治疗慢性阻塞性肺疾病的吸入性短效支气管扩张剂
Med Lett Drugs Ther. 2020 Sep 7;62(1606):e144-e145.
本文引用的文献
1
GOLD guidelines 2011: what are the implications for primary care?《慢性阻塞性肺疾病全球倡议》2011年指南：对初级保健有何影响？
Prim Care Respir J. 2012 Dec;21(4):437-41. doi: 10.4104/pcrj.2012.00058.
2
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病加重期后的肺康复治疗
Cochrane Database Syst Rev. 2011 Oct 5(10):CD005305. doi: 10.1002/14651858.CD005305.pub3.
3
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病的磷酸二酯酶4抑制剂
Cochrane Database Syst Rev. 2011 May 11(5):CD002309. doi: 10.1002/14651858.CD002309.pub3.
4
Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study.与严重慢性阻塞性肺疾病共存和死亡：多视角纵向定性研究。
BMJ. 2011 Jan 24;342:d142. doi: 10.1136/bmj.d142.
5
The use of roflumilast in COPD: a primary care perspective.罗氟司特在慢性阻塞性肺疾病中的应用：基层医疗视角
Prim Care Respir J. 2010 Dec;19(4):342-51. doi: 10.4104/pcrj.2010.00066.
6
Outpatient pulmonary rehabilitation following acute exacerbations of COPD.慢性阻塞性肺疾病急性加重期后的门诊肺康复。
Thorax. 2010 May;65(5):423-8. doi: 10.1136/thx.2009.124164.
7
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.慢性阻塞性肺疾病（COPD）在肺癌患者中的患病率增加，与年龄、性别和吸烟史无关。
Eur Respir J. 2009 Aug;34(2):380-6. doi: 10.1183/09031936.00144208. Epub 2009 Feb 5.
8
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.吸入器中联合使用皮质类固醇和长效β受体激动剂与安慰剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003794. doi: 10.1002/14651858.CD003794.pub3.
9
The course of C-reactive protein response in untreated upper respiratory tract infection.未经治疗的上呼吸道感染中C反应蛋白的反应过程。
Br J Gen Pract. 2004 Sep;54(506):653-8.
10
Time course of recovery of health status following an infective exacerbation of chronic bronchitis.慢性支气管炎感染性加重后健康状况恢复的时间进程。
Thorax. 2003 Jul;58(7):589-93. doi: 10.1136/thorax.58.7.589.
Zotero 插件